NCT00000526View on ClinicalTrials.gov

Cardiac Arrhythmia Suppression Trial (CAST)

PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

August 31, 1986

Study Completion Date

March 31, 1998

Conditions
Cardiovascular DiseasesCoronary DiseaseDeath, Sudden, CardiacHeart ArrestHeart DiseasesMyocardial InfarctionMyocardial IschemiaVentricular Arrhythmia
Interventions
DRUG

encainide

DRUG

flecainide

DRUG

moricizine

All Listed Sponsors
lead

National Heart, Lung, and Blood Institute (NHLBI)

NIH

NCT00000526 - Cardiac Arrhythmia Suppression Trial (CAST) | Biotech Hunter | Biotech Hunter